An Efficient CRISPR-Cas9 DNA Editing Methodology Applicable for iPSC Disease Modelling
暂无分享,去创建一个
M. Bellgrove | J. Polo | Z. Hawi | S. Lim | M. Herold | Xiaodong Liu | A. Namipashaki | Kealan Pugsley | Gui-zhi Sun
[1] K. Brennand,et al. Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics , 2020, Molecular and Cellular Neuroscience.
[2] M. Kampmann. CRISPR-based functional genomics for neurological disease , 2020, Nature Reviews Neurology.
[3] Hua Zhu,et al. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells , 2020, Acta Pharmacologica Sinica.
[4] D. Avramopoulos,et al. Modeling Psychiatric Disorder Biology with Stem Cells , 2020, Current Psychiatry Reports.
[5] D. Spengler,et al. Focus on Causality in ESC/iPSC-Based Modeling of Psychiatric Disorders , 2020, Cells.
[6] Nicholas A. Rossi,et al. Inference of CRISPR Edits from Sanger Trace Data , 2019, bioRxiv.
[7] T. Enoki,et al. Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs , 2019, Scientific Reports.
[8] Amar M. Singh. An Efficient Protocol for Single-Cell Cloning Human Pluripotent Stem Cells , 2019, Front. Cell Dev. Biol..
[9] M. Bellgrove,et al. Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family. , 2019, Stem cell research.
[10] Jian Chen,et al. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation , 2018, Scientific Reports.
[11] Robert Langer,et al. Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts. , 2018, Chemical reviews.
[12] Gang Bao,et al. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human haematopoietic stem and progenitor cells , 2018, Nature Medicine.
[13] Gregory McAllister,et al. p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells , 2018, Nature Medicine.
[14] A. Chen-Plotkin,et al. The Post-GWAS Era: From Association to Function. , 2018, American journal of human genetics.
[15] R. Kühn,et al. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9. , 2017, Methods.
[16] G. Church,et al. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies , 2016, Nature Protocols.
[17] Xiao-Hui Zhang,et al. Off-target Effects in CRISPR/Cas9-mediated Genome Engineering , 2015, Molecular therapy. Nucleic acids.
[18] Andrew J Petersen,et al. Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9. , 2015, Cell stem cell.
[19] J. Keith Joung,et al. Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo , 2014, Nature Biotechnology.
[20] Daesik Kim,et al. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins , 2014, Genome research.
[21] B. Conklin,et al. Isolation of single-base genome-edited human iPS cells without antibiotic selection , 2014, Nature Methods.
[22] P. Cahan,et al. Origins and implications of pluripotent stem cell variability and heterogeneity , 2013, Nature Reviews Molecular Cell Biology.
[23] Susan Lindquist,et al. Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations , 2011, Cell.
[24] Yoshiki Sasai,et al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. , 2010, Cell stem cell.
[25] J. Thomson,et al. Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. , 2010, Cell stem cell.
[26] J. Navarro,et al. Electron microscopy reveals the presence of viruses in mouse embryonic fibroblasts but neither in human embryonic fibroblasts nor in human mesenchymal cells used for hESC maintenance: toward an implementation of microbiological quality assurance program in stem cell banks. , 2008, Cloning and stem cells.
[27] Jack A. M. Leunissen,et al. Turning CFCs into salt. , 1996, Nucleic Acids Res..
[28] Susana Castro-Obregon,et al. New non-viral method for gene transfer into primary cells. , 2004, Methods.